SNN (Smith & Nephew) FFO


SNN Smith & Nephew PLC SNN
86 GF Score
Price $30.26
GF Value $31.44
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Smith & Nephew FFO?

FFO (Funds from operations) only applies to REITs.

SNN
86GF Score
Smith & Nephew PLC SNN
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Smith & Nephew (SNN) Overvalued in 2026?

Based on GuruFocus' analysis, Smith & Nephew stock appears to be undervalued. The current stock price of $30.26 is trading 3.8% below its estimated GF Value™ of $31.44. GuruFocus considers Smith & Nephew to be Fairly Valued.

Key valuation signals for SNN:

  • FFO:
  • GF Value™: $31.44 vs. price of $30.26 (3.8% below fair value)
  • GF Score™: 86/100 with 3 warning signs

No single metric tells the full story. See the SNN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Smith & Nephew Business Description

Address Hatters Lane, Building 5, Croxley Park, Watford, Hertfordshire, GBR, WD18 8YE
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
86GF Score

Get the complete analysis for SNN

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$30.26
Price
$31.44
GF Value